Scalper1 News
Big Swiss pharma Novartis (NVS) early Tuesday reported a mixed Q2 and affirmed its guidance, and its shares fell. Novartis posted earnings of $1.27 a share, down 7% from the year-earlier quarter but up 7% on a constant-currency basis. That was 3 cents above analysts’ consensus, according to Thomson Reuters, though it missed both the Capital IQ and FactSet consensus estimates. Sales slid 5% to $12.7 billion, about $250 million above consensus. On a Scalper1 News
Scalper1 News